Page 233 - Academic Press Encyclopedia of Physical Science and Technology 3rd BioTechnology
P. 233

P1: GTV/GWT  P2: GRB/GJP  QC: FYDFinal Pages
 Encyclopedia of Physical Science and Technology  EN011J-559  July 25, 2001  18:57







              Pharmacokinetics                                                                            811

              very rapidly into the circulation and bypass the first-pass  III.  DRUG DISTRIBUTION
              effect  of  the  liver.  Aerosols  with  sizes  greater  than  10
              µm are often trapped in the nasal passages or the phar-  Once a drug enters the circulation of an organism, the drug
              ynx and upper airway. Therapeutic aerosols, such as those  is mixed with the fluid circulating through the body. After
              used for acute obstructive asthma, need to be designed  absorption of a drug into the bloodstream, it is simulta-
              to deliver particles less than 10 µm. There is a clear ad-  neously distributed throughout the body and eliminated.
              vantage of direct delivery to the lungs in the treatment of  In mammals such as humans, the circulation consists of
              pulmonary disease in that many side effects of the drugs  the arteries, veins, and the heart. The lymphatic circula-
              which might occur if they were administered systemically  tion represents a third circulation, which returns proteins,
              can be avoided.                                   salts, and fluid from the interstitium to the venous circu-
                                                                lation; the flow rate in this system is slow relative to the
                                                                blood and is therefore less important for low-molecular
                                                                weight substances which rapidly transport across blood
              E.  Mathematical Approaches to
                                                                endothelia. However, the lymphatics can be significant in
                the Description of Absorption
                                                                the recirculation of high-molecular weight solutes in the
                and Bioavailability
                                                                body; the daily flow through the thoracic duct amounts to
              The definition of bioavailability given above includes ele-  1–2 plasma volumes per day.
              ments of the rate of drug entry into the target compartment  The distribution phase within the central volume of dis-
              as well as the total amount. Let us assume that the blood  tribution V d  is usually assumed to be very short relative
              circulation is the target compartment and that i.v. admin-  to the half-life of the drug t 1/2 . Unbound, highly lipid-
              istration is the standard route to which all others must be  soluble medications cross cell boundaries rapidly and may
              compared. Then F  may be calculated as the ratio of the  be quickly metabolized by the liver or distributed to fat.
              area under the plasma concentration versus time curve of  Medications which are highly bound (>99%) may be re-
              the test drug (or route) to that of the standard when equal  stricted to the vascular space but may have a large apparent
              doses are administered:                           volume of distribution. Most water-soluble medications,
                                                                either unbound or partially bound, are distributed rapidly
                                 AUC test route                 viathecirculationtoallregionsofthebodyand,depending
                             F =           ,             (9)
                                                                on the nature of the endothelial barrier, transport to some
                                    AUC iv
                                                                degree into the extravascular space of tissue. The drug
              where AUC  is the area under the plasma concentration  may transport from the extravascular space into a cell;
              versus time curve. If repeated doses are given, F can be  it may be bound locally; or it may undergo recirculation
              calculated from the ratio of the steady-state concentrations  to the vascular space, where it will undergo distribution
              C ss  which result from the same dose being given via the  again or be eliminated via several mechanisms discussed
              test route and i.v.:                              below. Data concerning binding, volume of distribution,
                                                                and mechanism of elimination on many drugs are tabu-
                                    C ss,test
                               F =       .              (10)    lated in useful, pocket-sized references which are listed in
                                                                the Bibliography.
                                    C ss,iv
                                                                  There may exist other compartments which exchange
              Actual rates of transfer across biological barriers are gen-  with the central circulation which are not well perfused but
              erallycalculatedfromEqs.(5)and(6).Tocalculatetherate  must be accounted for in modeling the kinetics of a drug
              coefficients of either equation, data consisting of concen-  (see Fig. 6). Muscle in a recumbent, resting human is rel-
              tration and volume versus time in both the compartment  atively poorly perfused compared to the liver or kidney.
              in which the drug is administered and in the receiving  General expansion of the muscle interstitium is termed
              compartment are required. If the target compartment is  edema and can significantly alter the magnitude of V d in
              the circulation, venous concentrations may be the only  the case of intensive care unit patients who have received
              data available. In this case, the rate of transfer can be ex-  massive amounts of intravenous fluids. In certain other
              pressed as the product of the plasma concentration and the  pathologic conditions, the extravascular space of patients
              volume of distribution divided by the total dose adminis-  may undergo extensive local increases and form so-called
              tered. This produces a fractional rate of absorption defined  “third spaces.” In the pleural space, this is called a pleu-
              by                                                ral effusion; in the peritoneal cavity, the fluid is termed
                                                                ascites; fluid around the heart is termed a pericardial ef-
                                           C plasma V d         fusion. Each of these fluid collections forms a compart-
                 fractional rate of absorption =    .   (11)
                                          dose × time           ment which can exchange with the normal extracellular
   228   229   230   231   232   233   234   235   236   237   238